LIS1

BIOLOGICAL2 trials

Sponsors

Xenothera SAS

Conditions

Kidney TransplantPeripheral T Cells Lymphoma (PTCL)

Phase 1

First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients

CompletedNCT04431219

Xenothera SASKidney Transplant

Start: 2019-11-26End: 2022-03-28Updated: 2022-08-17

Polyspecific Antibodies in Lymphoproliferative T-cell Disorders

RecruitingNCT06495723

Xenothera SASPeripheral T Cells Lymphoma (PTCL)

Start: 2024-07-09End: 2027-12-31Target: 54Updated: 2026-08-20

Related Papers

XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants

Frontiers in Immunology2021-11-1512 citations